SUCCESS STORIES DECEMBER 2023!

Always great news to share with you, we bring you the December 2023 success stories of French Tech Paris Saclay members!


Aurizeo won the regional final of the CIC Start Innovation competition in the START category. Find out more here

The national final will take place on December 12 at Station F (Paris 13). This could be an opportunity to meet them and discuss their project.

Register here


DAUMET raises €1.2m in seed funding to accelerate the decarbonization of luxury goods and jewelry thanks to its innovative golds.

DAUMET is a young CNRS spin-off founded in 2016 whose innovative technology saves precious metals.

Based in Paris (head office) and Saclay (workshop), the company has just been awarded one of the most prestigious certifications in the global CSR ecosystem: Positive Luxury’s Butterfly Mark certification.

Contact: deranlot@daumet.com


Félome is part of the Gene.iO program, an acceleration program designed to provide all the keys to a successful first fund-raising round or partnership agreement. More information HERE


After two successful launch years and a €1M fund-raising round in June 2022, Gibus Cycles is on course to reach a real milestone this year, 2023, with over 5,000 children’s bikes produced and sold.


Since 2021, that’s more than 7,000 bikes on which children are learning their first turns of the wheel with smiles on their faces to become the future cyclists of tomorrow!


Proteme, designated by the local Paris-Saclay jury for the French Tech Rise 2023 edition as Paris-Saclay’s deeptech champion, was able to pitch at Bercy on December 6 and meet with investors.

Proteme is developing an edible coating for fruit and vegetables to extend their shelf life and protect them from external aggression.

Contact: paul.malfoy@proteme.fr


Last July, STH BIOTECH was awarded the i-Lab Innovation Grand Prize! A second patent has just been filed, and their R&D is intensifying with the expansion of their laboratories at the Genopole incubator.

Contact: h.mailhac@sth-biotech.com